VRNA - Verona Pharma plc
106.91
0.120 0.112%
Share volume: 1,871,959
Last Updated: 10-06-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$106.79
0.12
0.00%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 06-30-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q2 2025 | |
| Report Date | 02-27-2025 | 04-29-2025 | 08-06-2025 | |
| Cash flow financing | 94.157 M | 13.457 M | 4.943 M | |
| Other financing cash flows | -3.339 M | 878.000 K | 4.943 M | |
| Cash flow | 64.786 M | 1.361 M | 0.000 | |
| Net income | -33.827 M | -16.319 M | 11.921 M | |
| Depreciation | 259.000 K | 295.000 K | 293.000 K | |
| Changes in inventories | 0.000 | 5.531 M | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -535.000 K | -535.000 K | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 535.000 K | 535.000 K | 0.000 | |
| Cash Change | 63.717 M | 1.658 M | 36.601 M |